Board of Directors
When the Hon. A. Anne McLellan takes up her appointment as the seventh chancellor of Dalhousie University in May, she will be returning to the school that prepared to become an outstanding academic, a leading lawyer and a widely respected political figure.…
When the Hon. A. Anne McLellan takes up her appointment as the seventh chancellor of Dalhousie University in May, she will be returning to the school that prepared to become an outstanding academic, a leading lawyer and a widely respected political figure.
“I’m deeply honoured,” said Ms. McLellan in the University’s press release. “Dalhousie has been such an important part of my life, and the opportunity to give back as chancellor is one I would have never expected, but it’s a great privilege.” Ms McLellan studied arts and then law at Dal in the late 1960s and early 1970s.
A member of our Foundation’s Board of Directors, Ms. McLellan works with the national law firm Bennett Jones LLP and is Distinguished Scholar in Residence at the University of Alberta in the Alberta Institute for American Studies. Prior to that, she held the positions of Deputy Prime Minister and Minister of Public Safety and Emergency Preparedness. She also served as Minister of Health, Minister of Justice and Attorney General, Minister of Natural Resources and Federal Interlocutor for Métis and Non-Status Indians. Before her time in politics, Ms. McLellan was a law professor, first at the University of New Brunswick and then the University of Alberta.
“I hope that I’m able to bring the perspective of a woman who has had the opportunity of a first-class education, and who then was able to use that education in ways that have contributed to our collective well-being.” said Ms. McLellan.
The end of the year brought new recognition to Dr. Michael Rudnicki, one of Canada’s leading stem cell scientists and a member of the Canadian Stem Cell Foundation’s Board of Directors.…
The end of the year brought new recognition to Dr. Michael Rudnicki, one of Canada’s leading stem cell scientists and a member of the Canadian Stem Cell Foundation’s Board of Directors. Dr. Rudnicki has been appointed an Officer of the Order of Canada for contributing to scientific breakthroughs in the area of muscle development.
“Stem cell research is really an area of strategic strength in Canada,” Dr. Rudnicki, CEO and Scientific Director of the Stem Cell Network, told the Ottawa Citizen in its report of the latest appointments.
From the discovery of stem cells in 1961 by Drs. Jim Till and Ernest McCulloch until today, Canada has played a leading role in stem cell research. Clearly, Canadian researchers “desire a better country” or desiderantes meliorem patriam, as the motto of the Order of Canada says.
The Order of Canada recognizes outstanding lifelong contributions made by Canadians in different fields. The honour of the Officer is the second highest recognition, awarded for a lifetime of achievement and merit of a high degree, especially in service to Canada or to humanity at large. Dr. Rudnicki’s appointment means the Foundation’s Board of Directors now includes six Order of Canada honorees, including L. Jacques Ménard, who holds the highest rank awarded, Companion.
Other honorees include rock stars Jim Cuddy and Greg Keelor of Blue Rodeo and actress/filmmaker Sarah Polley.
Dr. Rudnicki is a Senior Scientist and the Director of the Regenerative Medicine Program and the Sprott Centre for Stem Cell Research at the Ottawa Hospital Research Institute. He is also a Professor in the Department of Medicine at the University of Ottawa and holds the Canada Research Chair in Molecular Genetics.
His research focuses on the molecular mechanisms that regulate the determination, proliferation, and differentiation of stem cells tissue regeneration. His lab identified proteins that play a fundamental role in muscle stem cell function and that could be used to treat muscle diseases. Muscle diseases, such as Muscular Dystrophy in its different forms, are caused by genetic deficiency. There is hope that stem cells can help repair or replace damaged genes.